CStone Pharmaceuticals Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-91.21	-367.23	-902.68	-1,920
Depreciation & Amortization	49.74	56.93	42.03	20.06
Other Amortization	0.07	1.27	2.51	2.6
Loss (Gain) From Sale of Assets	-0.38	-178.89	-	0.9
Asset Writedown & Restructuring Costs	10.73	26.4	23.41	-
Loss (Gain) From Sale of Investments	-6.01	-0.06	62.03	64.21
Stock-Based Compensation	-2.81	36.99	142.06	222.67
Other Operating Activities	-2.31	-26.8	-54.48	85.93
Change in Accounts Receivable	48.51	-95.31	40.47	-117.6
Change in Inventory	-174.9	-95.46	30.42	-86.18
Change in Accounts Payable	-170.1	-121.6	-3.1	153.08
Change in Unearned Revenue	35	70	-	-6.76
Change in Other Net Operating Assets	-39.51	104.92	6.59	97.17
Operating Cash Flow	-343.18	-588.84	-610.74	-1,484
Capital Expenditures	-	-0.02	-	-91.03
Sale of Property, Plant & Equipment	0.41	0.11	-	-
Sale (Purchase) of Intangibles	-	151.57	-101.82	-58.11
Investment in Securities	-254.13	447.69	463.81	-687.48
Other Investing Activities	6.05	20.25	1.41	10.06
Investing Cash Flow	-247.68	619.61	363.39	-826.55
Short-Term Debt Issued	39.97	-	-	-
Long-Term Debt Issued	278	350	113.04	96.22
Total Debt Issued	317.97	350	113.04	96.22
Long-Term Debt Repaid	-312.02	-289.98	-75.3	-18.5
Net Debt Issued (Repaid)	5.95	60.02	37.75	77.72
Issuance of Common Stock	0.07	341.82	2.53	16.83
Other Financing Activities	-18.92	-13.49	-11.81	-2.24
Financing Cash Flow	-12.9	388.36	28.47	92.3
Foreign Exchange Rate Adjustments	-4.98	18.87	34.84	-63.55
Net Cash Flow	-608.73	437.99	-184.04	-2,282
Free Cash Flow	-343.18	-588.86	-610.74	-1,575
Free Cash Flow Margin	-84.28%	-126.95%	-126.88%	-646.26%
Free Cash Flow Per Share	-0.27	-0.47	-0.52	-1.35
Cash Interest Paid	11.9	10.18	11.81	2.24
Levered Free Cash Flow	-233.08	-495.11	-398.41	-1,054
Unlevered Free Cash Flow	-223.6	-487.73	-393.11	-1,052
Change in Working Capital	-301	-137.45	74.37	39.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.